Cancerify Logo
Log inSign up
Back to clinical trials
RecruitingInterventionalPhase 3

A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy With Immuno-oncology Therapy for Children and Adults With Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma

NCT ID: NCT05675410Sponsor: National Cancer Institute (NCI)Last updated: 2026-06-17

Summary

This phase III trial compares the effect of adding immunotherapy (brentuximab vedotin and nivolumab) to standard treatment (chemotherapy with or without radiation) to the standard treatment alone in improving survival in patients with stage I and II classical Hodgkin lymphoma. Brentuximab vedotin is in a class of medications called antibody-drug conjugates. It is made of a monoclonal antibody called brentuximab that is linked to a cytotoxic agent called vedotin. Brentuximab attaches to CD30 positive lymphoma cells in a targeted way and delivers vedotin to kill them. A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs such as doxorubicin hydrochloride, bleomycin sulfate, vinblastine sulfate, dacarbazine, and procarbazine hydrochloride work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Etoposide is in a class of medications known as podophyllotoxin derivatives. It blocks a certain enzyme needed for cell division and DNA repair and may kill cancer cells. Vincristine is in a class of medications called vinca alkaloids. It works by stopping cancer cells from growing and dividing and may kill them. Prednisone is in a class of medications called corticosteroids. It is used to reduce inflammation and lower the body's immune response to help lessen the side effects of chemotherapy drugs. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Adding immunotherapy to the standard treatment of chemotherapy with or without radiation may increase survival and/or fewer short-term or long-term side effects in patients with classical Hodgkin lymphoma compared to the standard treatment alone.

Detailed description

PRIMARY OBJECTIVES: I. To compare the progression-free survival (PFS) of a standard chemotherapy approach versus an immunotherapy (IO) approach (brentuximab vedotin and nivolumab) in patients with newly diagnosed early stage classic Hodgkin lymphoma (cHL) who have a rapid early response (RER) as determined by position emission tomography post cycle 2 (PET2) after 2 cycles of doxorubicin, bleomycin, vinblastine, dacarbazine (ABVD) chemotherapy. II. To compare the PFS of a standard chemotherapy approach versus an IO therapy approach (brentuximab vedotin and nivolumab) plus involved site radiation therapy (ISRT) in patients with newly diagnosed early stage cHL who have a slow early response (SER) as determined by PET2 after 2 cycles of ABVD chemotherapy. SECONDARY OBJECTIVES: I. To demonstrate non-inferiority of overall survival (OS) at 12 years of IO therapy versus standard therapy in early stage cHL patients who have a RER as determined by PET2 after 2 cycles of doxorubicin, bleomycin, vinblastine, dacarbazine (ABVD) chemotherapy. II. To evaluate the overall survival (OS) at 12 years of IO therapy versus standard therapy in early stage cHL patients who have a SER as determined by PET2 after 2 cycles of doxorubicin, bleomycin, vinblastine, dacarbazine (ABVD) chemotherapy. III. To demonstrate non-inferiority of overall survival (OS) at 12 years of IO therapy versus standard therapy in early stage cHL patients. IV. To evaluate in patients with newly diagnosed early stage cHL the PFS of a standard chemotherapy approach versus an IO therapy approach (brentuximab vedotin and nivolumab) in the overall cohort, in the favorable risk cohort, and in the unfavorable risk cohort. V. To evaluate the event-free survival (EFS) at 12 years of patients undergoing standard chemotherapy versus an IO therapy approach (brentuximab vedotin and nivolumab). VI. To compare the physician-reported treatment-related adverse event (AE) rates between a standard chemotherapy approach and an IO therapy approach (brentuximab vedotin and nivolumab) in patients with newly diagnosed early stage cHL. VII. To compare patient-reported adverse events using pediatric and adult versions of Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE), stratified by age groups, therapeutic arms, and receipt of radiation therapy (RT) over time. VIII. To evaluate changes in patient-reported fatigue, cognitive functioning, and health-related quality of life (HRQoL), e.g., emotional, physical, and role functioning, by treatment arm, using validated adult and pediatric measurement systems. IX. To evaluate self-reported late morbidities (e.g., cardiovascular, pulmonary and endocrine) over time for children, adolescents and adults undergoing standard chemotherapy versus an IO therapy approach (brentuximab vedotin and nivolumab) with and without RT using measures from the St. Jude Lifetime Cohort Study (SJLIFE). X. To evaluate fludeoxyglucose F-18 (FDG)-position emission tomography (PET) measurements of metabolic tumor burden (MTV and total lesion glycolysis \[TLG\]) at PET at baseline (PET1) as a predictive marker of PFS. XI. To evaluate the associations between race/ethnicity and key outcomes including early response to therapy, PFS and OS. EXPLORATORY OBJECTIVES: I. To evaluate the PFS of a standard chemotherapy approach versus an IO therapy approach (brentuximab vedotin and nivolumab) in patients with newly diagnosed early stage cHL across different age groups (ages 5-11 years, 12-21 years, 22-39 years, 40-60 years). II. To bank specimens for future correlative studies. III. To assess concordance and discordance of rapid central review and local institutional review of FDG PET 5-point score (5-PS; previously referred to as Deauville score) at baseline PET1, interim PET2 and end of systemic therapy PET-end of systemic therapy (EST) SER. IV. To assess the association between PFS and the quantitative FDG-PET/computed tomography (CT) parameters (PET MTV, TLG, delta-standardized uptake value \[SUV\] and PET SUV-based quantitative surrogates \[qPET\] of visual qualitative 5-PS) on measurements by automated measurements using convolutional neural networks (CNNs) through artificial-intelligence (AI) machine learning in the entire population. V. To assess the agreement between quantitative FDG-PET/CT parameters obtained using AI and those based on measurements by a trained imaging physician. VI. To compare patient-reported adverse events (via pediatric \[Ped\]-PRO-CTCAE and PRO-CTCAE) to provider adverse event reporting. VII. To evaluate the association between self-reported race/ethnicity and social determinants of health. VIII. To evaluate the associations between race/ethnicity and post-progression/post-relapse overall survival. IX. To evaluate the completion rates of PRO and health-related quality of life (HRQoL) contact forms at 1 year off treatment for the first 450 eligible patients. X. To collect contact information from participants for future re-contact. OUTLINE: Patients are stratified by risk status (favorable versus unfavorable) and then all patients receive the ABVD regimen (doxorubicin hydrochloride intravenously \[IV\] over 3-15 minutes, bleomycin sulfate IV over at least 10 minutes, vinblastine sulfate IV, and dacarbazine IV over 15-60 minutes) on days 1 and 15 of each treatment cycle. Cycles repeat every 28 days for up to 2 cycles in the absence of disease progression or unacceptable toxicity. Patients then undergo FDG-PET/CT or magnetic resonance imaging (MRI) and are identified as RER or SER. Patients with a favorable risk status and RER are randomized to Arm A or Arm B. Patients with a favorable risk status and SER are randomized to Arm C or Arm D. Patients with an unfavorable risk status and RER are randomized to Arm E or Arm F. Patients with an unfavorable risk status and SER are randomized to Arm G or Arm H. ARM A (RER, FAVORABLE): Patients receive ABVD IV for an additional 2 cycles on study. Each cycle lasts 28 days and ABVD is administered on days 1 and 15 of each cycle in the absence of disease progression or unacceptable toxicity. Patients also undergo FDG-PET, PET, PET-CT, PET-MRI, CT, and/or MRI throughout the trial. Patients may also undergo blood sample collection on trial. ARM B (RER, FAVORABLE): Patients receive brentuximab vedotin IV over 30 minutes and nivolumab IV over 30 minutes once during each treatment cycle. Cycles repeat every 28 days for up to 4 cycles in the absence of disease progression or unacceptable toxicity. Patients also undergo FDG-PET, PET, PET-CT, PET-MRI, CT, and/or MRI throughout the trial. Patients may also undergo blood sample collection on trial. ARM C (SER, FAVORABLE): Patients receive either the eBEACOPP regimen (doxorubicin hydrochloride IV over 3-15 minutes on day 1, cyclophosphamide IV over 30-60 minutes on day 1, etoposide or etoposide phosphate IV over 2-4 hours on days 1-3, prednisone or prednisolone orally \[PO\] twice daily \[BID\] on days 1-14, procarbazine hydrochloride PO on days 1-7, bleomycin sulfate IV over at least 10 minutes on day 8, and vincristine sulfate IV on day 8 of each cycle) or the eBPDac regimen (doxorubicin hydrochloride IV 3-15 minutes on day 1, cyclophosphamide IV 30-60 minutes on day 1, etoposide or etoposide phosphate IV over 2-4 hours on days 1-3, prednisone or prednisolone PO BID on days 1-14, dacarbazine IV over 15-60 minutes on days 2 \& 3, bleomycin sulfate IV over at least 10 minutes on day 4, 5, 6, 7, or 8, vincristine sulfate IV on day 4, 5, 6, 7, or 8 of each cycle). Cycles repeat every 28 days for up to 2 cycles in the absence of disease progression or unacceptable toxicity. Subsequently, patients undergo ISRT. Patients also undergo FDG-PET, PET, PET-CT, PET-MRI, CT, and/or MRI throughout the trial. Patients may also undergo blood sample collection on trial. ARM D (SER, FAVORABLE): Patients receive brentuximab vedotin IV and nivolumab IV as in arm B followed by ISRT. Patients also undergo FDG-PET, PET, PET-CT, PET-MRI, CT, and/or MRI throughout the trial. Patients may also undergo blood sample collection on trial. ARM E (RER, UNFAVORABLE): Patients receive AVD regimen (doxorubicin hydrochloride IV over 3-15 minutes, vinblastine IV, and dacarbazine IV over 15-60 minutes) on days 1 and 15 of each treatment cycle. Cycles repeat every 28 days for up to 4 cycles in the absence of disease progression or unacceptable toxicity. Patients also undergo FDG-PET, PET, PET-CT, PET-MRI, CT, and/or MRI throughout the trial. Patients may also undergo blood sample collection on trial. ARM F (RER, UNFAVORABLE): Patients receive treatment as in arm B. Patients also undergo FDG-PET, PET, PET-CT, PET-MRI, CT, and/or MRI throughout the trial. Patients may also undergo blood sample collection on trial. ARM G (SER, UNFAVORABLE): Patients receive treatment and imaging, and may undergo blood sample collection as in arm C. ARM H (SER, UNFAVORABLE): Patients receive treatment and imaging, and may undergo blood sample collection as in arm D. After completion of study treatment, patients are followed up every 3 months for the first year, then every 6 months for the second and third year, then annually until 12 years from date of registration.

Arms & interventions

  • ProcedureBiospecimen Collection

    Undergo blood sample collection

  • BiologicalBleomycin Sulfate

    Given IV

  • DrugBrentuximab Vedotin

    Given IV

  • ProcedureComputed Tomography

    Undergo CT and/or PET-CT

  • DrugCyclophosphamide

    Given IV

  • DrugDacarbazine

    Given IV

  • DrugDoxorubicin Hydrochloride

    Given IV

  • DrugEtoposide

    Given IV

  • DrugEtoposide Phosphate

    Given IV

  • OtherFludeoxyglucose F-18

    Undergo FDG-PET

  • RadiationInvolved-site Radiation Therapy

    Undergo ISRT

  • ProcedureMagnetic Resonance Imaging

    Undergo MRI and/or PET-MRI

  • BiologicalNivolumab

    Given IV

  • ProcedurePositron Emission Tomography

    Undergo FDG-PET, PET, PET-CT, and/or PET-MRI

  • DrugPrednisolone

    Given PO

  • DrugPrednisone

    Given PO

  • DrugProcarbazine Hydrochloride

    Given PO

  • OtherQuestionnaire Administration

    Ancillary studies

  • DrugVinblastine Sulfate

    Given IV

  • DrugVincristine Sulfate

    Given IV

Outcome measures

Primary

  • Progression-free survival (PFS) in rapid early responder (RER) patients

    Will compare the PFS of RER patients randomized to immunotherapy (IO) therapy (brentuximab vedotin-nivolumab) against those randomized to standard therapy. PFS curves will be estimated separately by arm using Kaplan Meier methodology, and the test will be a 1-sided log-rank test between the (pooled) IO and standard arms, stratified according to the stratification factors at randomization and including all eligible and evaluable randomized patients.

    Time frame: From the time of randomization to the earliest time of disease relapse, progression, or death due to any cause, assessed up to 3 years after the randomization of the last patient or when reaching 124 events, whichever comes first

  • PFS in slow-early responder (SER) patients

    Will compare PFS among SER patients randomized to IO therapy and involved-site radiation therapy against arms containing standard therapy. PFS curves will be estimated separately by arm using Kaplan Meier methodology, and the test will be a 1-sided log-rank test between the (pooled) IO and standard arms, stratified according to the stratification factors at randomization and including all eligible and evaluable randomized patients.

    Time frame: From the time of randomization to the earliest time of disease relapse, progression, or death due to any cause, assessed up to 3 years after the randomization of the last patient or when reaching 71 events, whichever comes first

Secondary

  • Overall survival (OS) in RER patients

    Time frame: Time from randomization to death due to any cause, assessed up to 12 years after the last enrollment

  • OS in SER patients

    Time frame: Time from randomization to death due to any cause, assessed up to 12 years after the last enrollment

  • OS for entire patient population

    Time frame: Time from randomization to death due to any cause, assessed at 12 years after the last enrollment

  • PFS for favorable risk patients

    Time frame: Up to 12 years

  • PFS for unfavorable risk patients

    Time frame: Up to 12 years

  • PFS for entire population

    Time frame: Up to 12 years

  • Event-free survival (EFS)

    Time frame: Time from randomization to the earliest of progression, relapse, second malignancy, or death due to any cause, assessed up to 12 years from last enrollment

  • Incidence of adverse events (AEs)

    Time frame: Assessed up to 12 years from last enrollment

  • Patient reported outcomes (PRO)-CTCAE

    Time frame: Assessed up to 12 years from last enrollment

  • Patient-reported fatigue

    Time frame: Baseline up to 1 year from end of study treatment

  • Patient-reported cognitive deficits

    Time frame: Baseline up to 1 year from end of study treatment

  • Patient-reported health-related quality of life

    Time frame: Baseline up to 1 year from end of study treatment

  • Incidence of self-reported late morbidities

    Time frame: Assessed up to 12 years from last enrollment

  • Effect of metabolic tumor burden (MTV) on PFS

    Time frame: At baseline prior to initiation of therapy

  • Effect of total lesion glycolysis (TLG) on PFS

    Time frame: At baseline prior to initiation of therapy

  • Contribution of social determinants of health (SDOH) to PET2 response by race and ethnicity

    Time frame: After Cycle 2 of treatment (1 cycle = 28 days)

  • Contribution of SDOH to PFS by race and ethnicity

    Time frame: Assessed up to 12 years after last enrollment

  • Contribution of SDOH to OS by race and ethnicity

    Time frame: Assessed up to 12 years after last enrollment

Eligibility criteria

Sex: AllAge: 5 Years to 60 YearsHealthy volunteers: No
Inclusion Criteria: * Patients must be 5 to 60 years of age at the time of enrollment * Patients with newly diagnosed untreated histologically confirmed classic Hodgkin lymphoma (cHL) (nodular sclerosis, mixed cellularity, lymphocyte-rich, or lymphocyte-depleted, or not otherwise specified \[NOS\]) with stage I or II disease * Patients must have bidimensionally measurable disease (at least one lesion with longest diameter \>= 1.5 cm) * Patients must have a whole body or limited whole body PET scan performed within 42 days prior to enrollment. PET-CT is strongly preferred. PET-MRI allowed if intravenous contrast enhanced CT is also obtained * Pediatric patients (age 5-17 years) with known or suspected mediastinal disease must have an upright posteroanterior (PA) chest X-ray (CXR) for assessment of bulky mediastinal disease. * Note: Pediatric patients who have received both a CT chest and upright PA CXR may meet the definition of bulk through either modality. * Patients \>= 18 years must have a performance status corresponding to Zubrod scores of 0, 1 or 2 * Patients =\< 17 years of age must have a Lansky performance score of \>= 50 * Pediatric patients (age 5-17 years): A serum creatinine based on age/sex as follows (within 28 days prior to enrollment): * 2 to \< 6 years (age): 0.8 mg/dL (male), 0.8 mg/dL (female) * 6 to \< 10 years (age): 1 mg/dL (male), 1 mg/dL (female) * 10 to \< 13 years (age): 1.2 mg/dL (male), 1.2 mg/dL (female) * 13 to \< 16 years (age): 1.5 mg/dL (male), 1.4 mg/dL (female) * \>= 16 years (age): 1.7 mg/dL (male), 1.4 mg/dL (female) OR a 24 hour urine creatinine clearance \>= 50 mL/min/1.73 m\^2 (within 28 days prior to enrollment) OR a glomerular filtration rate (GFR) \>= 50 mL/min/1.73 m\^2 (within 28 days prior to enrollment). GFR must be performed using direct measurement with a nuclear blood sampling method OR direct small molecule clearance method (iothalamate or other molecule per institutional standard) * Note: Estimated GFR (eGFR) from serum or plasma creatinine, cystatin C or other estimates are not acceptable for determining eligibility * For adult patients (age 18 years or older) (within 28 days prior to enrollment): Creatinine clearance \>= 30 mL/min, as estimated by the Cockcroft and Gault formula or a 24-hour urine collection. The creatinine value used in the calculation must have been obtained within 28 days prior to registration. Estimated creatinine clearance is based on actual body weight * Total bilirubin =\< 2 x upper limit of normal (ULN) (within 28 days prior to enrollment) * Unless due to Gilbert's disease, lymphomatous involvement of liver or vanishing bile duct syndrome * Aspartate aminotransferase (AST) =\< 3 x ULN (within 28 days prior to enrollment) * Unless due to Gilbert's disease, lymphomatous involvement of liver or vanishing bile duct syndrome * Alanine aminotransferase (ALT) =\< 3 x ULN (within 28 days prior to enrollment) * Unless due to Gilbert's disease, lymphomatous involvement of liver or vanishing bile duct syndrome * Shortening fraction of \>= 27% by echocardiogram (ECHO), multigated acquisition scan (MUGA), or functional cardiac imaging scan (within 28 days prior to enrollment) or ejection fraction of \>= 50% by radionuclide angiogram, ECHO, MUGA, or cardiac imaging scan (within 28 days prior to enrollment) * Diffusion capacity of the lung for carbon monoxide (DLCO) \>= 50% of predicted value as corrected for hemoglobin by pulmonary function test (PFT) (within 28 days prior to enrollment). If unable to obtain PFTs, the criterion is: a pulse oximetry reading of \> 92% on room air * Known human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for this trial * For patients with evidence of chronic hepatitis B virus (HBV) infection, the HBV viral load must be undetectable on suppressive therapy, if indicated. Patients with a history of hepatitis C virus (HCV) infection must have been treated and cured. For patients with HCV infection who are currently on treatment, they are eligible if they have an undetectable HCV viral load Exclusion Criteria: * Patients with nodular lymphocyte predominant Hodgkin lymphoma * Patients with a history of active interstitial pneumonitis or interstitial lung disease * Patients with a diagnosis of inherited or acquired immunodeficiency that is poorly controlled or requiring active medications, such as primary immunodeficiency syndromes or organ transplant recipients * Patients with any known uncontrolled intercurrent illness that would jeopardize the patient's safety such as infection, autoimmune conditions, cardiac arrhythmias, angina pectoris, and gastrointestinal disorders affecting swallowing and/or absorption of pills * Patients with a condition requiring systemic treatment with either corticosteroids (defined as equivalent to \> 10 mg daily predniSONE for patients \>= 18 years or \> 0.5 mg/kg \[up to 10 mg/day\] for patients \< 18 years) or other immunosuppressive medications within 14 days prior to enrollment * Note: Replacement therapy such as thyroxine, insulin, or physiologic corticosteroid for adrenal or pituitary insufficiency is not considered a form of systemic treatment. Inhaled or topical steroids, and adrenal replacement doses (=\< 10 mg daily for patients \>= 18 years or =\< 0.5 mg/kg \[up to 10 mg/day\] predniSONE equivalents) are permitted in the absence of active autoimmune disease * Note: Steroid use for the control of Hodgkin lymphoma symptoms is allowable, but must be discontinued by cycle 1, day 1 * Short term use of corticosteroids for premedication or treatment of an allergy or hypersensitivity is considered an acceptable use of corticosteroids. * Patients with peripheral neuropathy \> grade 1 at the time of enrollment or patients with known Charcot-Marie-Tooth syndrome * Patients with a prior or concurrent malignancy whose natural history or treatment has the potential to interfere with the safety or efficacy assessment of the investigational regimen * Administration of prior chemotherapy, radiation, or antibody-based treatment for cHL * Prior solid organ transplant * Prior allogeneic stem cell transplantation * Live vaccine within 30 days prior to planned day 1 of protocol therapy (e.g., measles, mumps, rubella, varicella, yellow fever, rabies, bacillus Calmette Guerin \[BCG\], oral polio vaccine, and oral typhoid). Administration of messenger ribonucleic acid (mRNA) vaccines are permitted * Female patients who are pregnant since fetal toxicities and teratogenic effects have been noted for several of the study drugs. A pregnancy test within 28 days prior to enrollment is required for female patients of childbearing potential * Lactating females who plan to breastfeed their infants starting with the first dose of study therapy and for at least 6 months after the last treatment * Sexually active patients of reproductive potential who have not agreed to use a highly effective contraceptive method for the duration of their study drug therapy. Following therapy, patients will be advised to use contraception as per institutional practice or as listed below for investigational agents, whichever is longer * Men and women of childbearing potential (WOCBP) must use effective contraception during the study and for 2 months for WOCBP and 4 months for men, after last dose of brentuximab vedotin * WOCBP must continue contraception for a period of at least 5 months after the last dose of nivolumab * All patients and/or their parents or legal guardians must sign a written informed consent * All institutional, Food and Drug Administration (FDA), and National Cancer Institute (NCI) requirements for human studies must be met

Study locations (390)

Children's Hospital of Alabama

Birmingham, Alabama, 35233

Recruiting
Site Public Contact · Contact
205-638-9285oncologyresearch@peds.uab.edu
Ana C. Xavier · Principal Investigator

USA Health Strada Patient Care Center

Mobile, Alabama, 36604

Recruiting
Site Public Contact · Contact
800-388-8721
Hamayun Imran · Principal Investigator

Providence Alaska Medical Center

Anchorage, Alaska, 99508

Recruiting
Site Public Contact · Contact
907-212-6871AKPAMC.OncologyResearchSupport@providence.org
Brenda J. Wittman · Principal Investigator

CTCA at Western Regional Medical Center

Goodyear, Arizona, 85338

Recruiting
Site Public Contact · Contact
623-207-3000
Jeffrey R. Schriber · Principal Investigator

Banner Children's at Desert

Mesa, Arizona, 85202

Recruiting
Site Public Contact · Contact
480-412-3100
Joseph C. Torkildson · Principal Investigator

Phoenix Childrens Hospital

Phoenix, Arizona, 85016

Recruiting
Site Public Contact · Contact
602-546-0920
Alexandra M. Walsh · Principal Investigator

Arkansas Children's Hospital

Little Rock, Arkansas, 72202-3591

Recruiting
Site Public Contact · Contact
501-364-7373
Michael W. Bishop · Principal Investigator

Mercy Cancer Center - Carmichael

Carmichael, California, 95608

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Mercy San Juan Medical Center

Carmichael, California, 95608

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@commonspirit.org
Shahzad Siddique · Principal Investigator

City of Hope Corona

Corona, California, 92882

Recruiting
Site Public Contact · Contact
626-256-4673becomingapatient@coh.org
Alex F. Herrera · Principal Investigator

UC Irvine Health Cancer Center-Newport

Costa Mesa, California, 92627

Recruiting
Site Public Contact · Contact
877-827-8839
Nicole Foley · Principal Investigator

Kaiser Permanente Downey Medical Center

Downey, California, 90242

Recruiting
Site Public Contact · Contact
626-564-3455
Robert M. Cooper · Principal Investigator

City of Hope Comprehensive Cancer Center

Duarte, California, 91010

Recruiting
Site Public Contact · Contact
800-826-4673becomingapatient@coh.org
Alex F. Herrera · Principal Investigator

Kaiser Permanente Dublin

Dublin, California, 94568

Recruiting
Site Public Contact · Contact
877-642-4691
Sachdev P. Thomas · Principal Investigator

Mercy Cancer Center - Elk Grove

Elk Grove, California, 95758

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Kaiser Permanente-Fremont

Fremont, California, 94538

Recruiting
Site Public Contact · Contact
877-642-4691Kpoct@kp.org
Sachdev P. Thomas · Principal Investigator

Kaiser Permanente Fresno Orchard Plaza

Fresno, California, 93720

Suspended

Kaiser Permanente-Fresno

Fresno, California, 93720

Recruiting
Site Public Contact · Contact
877-642-4691Kpoct@kp.org
Sachdev P. Thomas · Principal Investigator

City of Hope Seacliff

Huntington Beach, California, 92648

Recruiting
Site Public Contact · Contact
626-256-4673
Alex F. Herrera · Principal Investigator

UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care

Irvine, California, 92612

Recruiting
Site Public Contact · Contact
877-827-8839ucstudy@uci.edu
Nicole Foley · Principal Investigator

City of Hope at Irvine Lennar

Irvine, California, 92618

Recruiting
Site Public Contact · Contact
877-467-3411
Alex F. Herrera · Principal Investigator

City of Hope Antelope Valley

Lancaster, California, 93534

Recruiting
Site Public Contact · Contact
800-826-4673becomingapatient@coh.org
Alex F. Herrera · Principal Investigator

Loma Linda University Medical Center

Loma Linda, California, 92354

Recruiting
Site Public Contact · Contact
909-558-4050
Albert Kheradpour · Principal Investigator

Miller Children's and Women's Hospital Long Beach

Long Beach, California, 90806

Recruiting
Site Public Contact · Contact
562-933-5600
Jacqueline N. Casillas · Principal Investigator

City of Hope at Long Beach Elm

Long Beach, California, 90813

Recruiting
Site Public Contact · Contact
877-467-3411
Alex F. Herrera · Principal Investigator

Children's Hospital Los Angeles

Los Angeles, California, 90027

Recruiting
Site Public Contact · Contact
323-361-4110
Andrew Doan · Principal Investigator

Cedars-Sinai Medical Center

Los Angeles, California, 90048

Recruiting
Site Public Contact · Contact
310-423-2133Cancer.trial.info@cshs.org
Nicole M. Baca · Principal Investigator

Kaiser Permanente- Modesto MOB II

Modesto, California, 95356

Suspended

Kaiser Permanente-Modesto

Modesto, California, 95356

Recruiting
Site Public Contact · Contact
877-642-4691Kpoct@kp.org
Sachdev P. Thomas · Principal Investigator

City of Hope Newport Beach

Newport Beach, California, 92660

Recruiting
Site Public Contact · Contact
877-467-3411
Alex F. Herrera · Principal Investigator

Kaiser Permanente-Oakland

Oakland, California, 94611

Recruiting
Site Public Contact · Contact
877-642-4691Kpoct@kp.org
Aarati V. Rao · Principal Investigator

Children's Hospital of Orange County

Orange, California, 92868

Recruiting
Site Public Contact · Contact
714-509-8646oncresearch@choc.org
Elyssa M. Rubin · Principal Investigator

UC Irvine Health/Chao Family Comprehensive Cancer Center

Orange, California, 92868

Recruiting
Site Public Contact · Contact
877-827-8839ucstudy@uci.edu
Nicole Foley · Principal Investigator

Mercy Cancer Center - Rocklin

Rocklin, California, 95765

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Kaiser Permanente Downtown Commons

Sacramento, California, 95814

Recruiting
Site Public Contact · Contact
877-642-4691kpoct@kp.org
Sachdev P. Thomas · Principal Investigator

Mercy Cancer Center - Sacramento

Sacramento, California, 95816

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Kaiser Permanente-South Sacramento

Sacramento, California, 95823

Recruiting
Site Public Contact · Contact
877-642-4691Kpoct@kp.org
Sachdev P. Thomas · Principal Investigator

Rady Children's Hospital - San Diego

San Diego, California, 92123

Recruiting
Site Public Contact · Contact
858-966-5934
William D. Roberts · Principal Investigator

Naval Medical Center -San Diego

San Diego, California, 92134

Recruiting
Site Public Contact · Contact
619-532-8712
Yoko T. Udaka · Principal Investigator

Kaiser Permanente-San Francisco

San Francisco, California, 94115

Recruiting
Site Public Contact · Contact
877-642-4691Kpoct@kp.org
Sachdev P. Thomas · Principal Investigator

Kaiser Permanente-Santa Teresa-San Jose

San Jose, California, 95119

Recruiting
Site Public Contact · Contact
877-642-4691Kpoct@kp.org
Sachdev P. Thomas · Principal Investigator

Kaiser Permanente San Leandro

San Leandro, California, 94577

Recruiting
Site Public Contact · Contact
877-642-4691Kpoct@kp.org
Sachdev P. Thomas · Principal Investigator

Kaiser San Rafael-Gallinas

San Rafael, California, 94903

Recruiting
Site Public Contact · Contact
877-642-4691Kpoct@kp.org
Sachdev P. Thomas · Principal Investigator

Santa Barbara Cottage Hospital

Santa Barbara, California, 93102

Recruiting
Site Public Contact · Contact
805-682-7300
Shivani Upadhyay · Principal Investigator

Kaiser Permanente-Santa Rosa

Santa Rosa, California, 95403

Recruiting
Site Public Contact · Contact
877-642-4691Kpoct@kp.org
Sachdev P. Thomas · Principal Investigator

City of Hope South Pasadena

South Pasadena, California, 91030

Recruiting
Site Public Contact · Contact
800-826-4673becomingapatient@coh.org
Alex F. Herrera · Principal Investigator

Kaiser Permanente-South San Francisco

South San Francisco, California, 94080

Recruiting
Site Public Contact · Contact
877-642-4691Kpoct@kp.org
Sachdev P. Thomas · Principal Investigator

City of Hope South Bay

Torrance, California, 90503

Recruiting
Site Public Contact · Contact
877-467-3411
Alex F. Herrera · Principal Investigator

City of Hope Upland

Upland, California, 91786

Recruiting
Site Public Contact · Contact
800-826-4673becomingapatient@coh.org
Alex F. Herrera · Principal Investigator

Kaiser Permanente-Vallejo

Vallejo, California, 94589

Recruiting
Site Public Contact · Contact
877-642-4691Kpoct@kp.org
Sachdev P. Thomas · Principal Investigator

Kaiser Permanente-Walnut Creek

Walnut Creek, California, 94596

Recruiting
Site Public Contact · Contact
877-642-4691Kpoct@kp.org
Sachdev P. Thomas · Principal Investigator

Woodland Memorial Hospital

Woodland, California, 95695

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Children's Hospital Colorado

Aurora, Colorado, 80045

Recruiting
Site Public Contact · Contact
303-764-5056josh.b.gordon@nsmtp.kp.org
Kelly W. Maloney · Principal Investigator

UCHealth University of Colorado Hospital

Aurora, Colorado, 80045

Recruiting
Site Public Contact · Contact
720-848-0650
Sarah Milgrom · Principal Investigator

UCHealth Memorial Hospital Central

Colorado Springs, Colorado, 80909

Recruiting
Site Public Contact · Contact
719-365-2406
Sarah Milgrom · Principal Investigator

Memorial Hospital North

Colorado Springs, Colorado, 80920

Recruiting
Site Public Contact · Contact
719-364-6700
Sarah Milgrom · Principal Investigator

Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center

Denver, Colorado, 80218

Recruiting
Site Public Contact · Contact
303-832-2344PSGResearchSharedMailbox@HCAHealthcare.com
Florence Choo · Principal Investigator

Poudre Valley Hospital

Fort Collins, Colorado, 80524

Recruiting
Site Public Contact · Contact
970-297-6150
Sarah Milgrom · Principal Investigator

Cancer Care and Hematology-Fort Collins

Fort Collins, Colorado, 80528

Recruiting
Site Public Contact · Contact
888-823-5923ctsucontact@westat.com
Sarah Milgrom · Principal Investigator

UCHealth Greeley Hospital

Greeley, Colorado, 80631

Recruiting
Site Public Contact · Contact
888-823-5923ctsucontact@westat.com
Sarah Milgrom · Principal Investigator

Medical Center of the Rockies

Loveland, Colorado, 80538

Recruiting
Site Public Contact · Contact
970-203-7083
Sarah Milgrom · Principal Investigator

Smilow Cancer Hospital-Derby Care Center

Derby, Connecticut, 06418

Recruiting
Site Public Contact · Contact
203-785-5702canceranswers@yale.edu
Farzana Pashankar · Principal Investigator

Smilow Cancer Hospital Care Center-Fairfield

Fairfield, Connecticut, 06824

Recruiting
Site Public Contact · Contact
203-785-5702canceranswers@yale.edu
Farzana Pashankar · Principal Investigator

Smilow Cancer Hospital Care Center at Glastonbury

Glastonbury, Connecticut, 06033

Recruiting
Site Public Contact · Contact
203-785-5702canceranswers@yale.edu
Farzana Pashankar · Principal Investigator

Smilow Cancer Hospital Care Center at Greenwich

Greenwich, Connecticut, 06830

Recruiting
Site Public Contact · Contact
203-785-5702canceranswers@yale.edu
Farzana Pashankar · Principal Investigator

Smilow Cancer Hospital Care Center - Guilford

Guilford, Connecticut, 06437

Recruiting
Site Public Contact · Contact
203-785-5702canceranswers@yale.edu
Farzana Pashankar · Principal Investigator

Smilow Cancer Hospital Care Center at Saint Francis

Hartford, Connecticut, 06105

Recruiting
Site Public Contact · Contact
203-785-5702canceranswers@yale.edu
Farzana Pashankar · Principal Investigator

Connecticut Children's Medical Center

Hartford, Connecticut, 06106

Recruiting
Site Public Contact · Contact
860-545-9981
Michael S. Isakoff · Principal Investigator

Yale University

New Haven, Connecticut, 06520

Recruiting
Site Public Contact · Contact
203-785-5702canceranswers@yale.edu
Farzana Pashankar · Principal Investigator

Yale-New Haven Hospital North Haven Medical Center

North Haven, Connecticut, 06473

Recruiting
Site Public Contact · Contact
203-785-5702canceranswers@yale.edu
Farzana Pashankar · Principal Investigator

Smilow Cancer Hospital Care Center at Long Ridge

Stamford, Connecticut, 06902

Recruiting
Site Public Contact · Contact
203-785-5702canceranswers@yale.edu
Farzana Pashankar · Principal Investigator

Smilow Cancer Hospital-Torrington Care Center

Torrington, Connecticut, 06790

Recruiting
Site Public Contact · Contact
203-785-5702canceranswers@yale.edu
Farzana Pashankar · Principal Investigator

Smilow Cancer Hospital Care Center-Trumbull

Trumbull, Connecticut, 06611

Recruiting
Site Public Contact · Contact
203-785-5702canceranswers@yale.edu
Farzana Pashankar · Principal Investigator

Smilow Cancer Hospital-Waterbury Care Center

Waterbury, Connecticut, 06708

Recruiting
Site Public Contact · Contact
203-785-5702canceranswers@yale.edu
Farzana Pashankar · Principal Investigator

Smilow Cancer Hospital Care Center - Waterford

Waterford, Connecticut, 06385

Recruiting
Site Public Contact · Contact
203-785-5702canceranswers@yale.edu
Farzana Pashankar · Principal Investigator

Alfred I duPont Hospital for Children

Wilmington, Delaware, 19803

Recruiting
Site Public Contact · Contact
302-651-5572Allison.bruce@nemours.org
Vibhuti Agarwal · Principal Investigator

MedStar Georgetown University Hospital

Washington D.C., District of Columbia, 20007

Recruiting
Site Public Contact · Contact
202-444-2223
Caileigh Pudela · Principal Investigator

Children's National Medical Center

Washington D.C., District of Columbia, 20010

Recruiting
Site Public Contact · Contact
202-476-2800OncCRC_OnCall@childrensnational.org
Jeffrey S. Dome · Principal Investigator

Broward Health Medical Center

Fort Lauderdale, Florida, 33316

Recruiting
Site Public Contact · Contact
302-651-5572Allison.bruce@nemours.org
Hector M. Rodriguez-Cortes · Principal Investigator

Golisano Children's Hospital of Southwest Florida

Fort Myers, Florida, 33908

Recruiting
Site Public Contact · Contact
239-343-5333molly.arnstrom@leehealth.org
Emad K. Salman · Principal Investigator

UF Health Cancer Institute - Gainesville

Gainesville, Florida, 32610

Recruiting
Site Public Contact · Contact
352-273-8010
Brian Stover · Principal Investigator

Memorial Regional Hospital/Joe DiMaggio Children's Hospital

Hollywood, Florida, 33021

Recruiting
Site Public Contact · Contact
954-265-1847OHR@mhs.net
Iftikhar Hanif · Principal Investigator

Nemours Children's Clinic-Jacksonville

Jacksonville, Florida, 32207

Recruiting
Site Public Contact · Contact
302-651-5572Allison.bruce@nemours.org
Vibhuti Agarwal · Principal Investigator

Mayo Clinic in Florida

Jacksonville, Florida, 32224-9980

Recruiting
Site Public Contact · Contact
855-776-0015
Mira Kohorst · Principal Investigator

University of Miami Miller School of Medicine-Sylvester Cancer Center

Miami, Florida, 33136

Recruiting
Site Public Contact · Contact
305-243-2647
Warren Alperstein · Principal Investigator

Nicklaus Children's Hospital

Miami, Florida, 33155

Recruiting
Site Public Contact · Contact
888-624-2778
Maggie E. Fader · Principal Investigator

Mount Sinai Medical Center

Miami Beach, Florida, 33140

Recruiting
Site Public Contact · Contact
305-674-2625Yvonne.Enriquez@msmc.com
Jacqueline C. Barrientos · Principal Investigator

AdventHealth Orlando

Orlando, Florida, 32803

Recruiting
Site Public Contact · Contact
407-303-2090FH.Cancer.Research@flhosp.org
Fouad M. Hajjar · Principal Investigator

Arnold Palmer Hospital for Children

Orlando, Florida, 32806

Recruiting
Site Public Contact · Contact
321-841-5357Jennifer.spinelli@orlandohealth.com
Jaime M. Libes-Bander · Principal Investigator

Nemours Children's Hospital

Orlando, Florida, 32827

Recruiting
Site Public Contact · Contact
302-651-5572Allison.bruce@nemours.org
Vibhuti Agarwal · Principal Investigator

Nemours Children's Clinic - Pensacola

Pensacola, Florida, 32504

Recruiting
Site Public Contact · Contact
helpdesk@childrensoncologygroup.org
Jeffrey H. Schwartz · Principal Investigator

Sacred Heart Hospital

Pensacola, Florida, 32504

Suspended

Johns Hopkins All Children's Hospital

St. Petersburg, Florida, 33701

Recruiting
Site Public Contact · Contact
727-767-4784Ashley.Repp@jhmi.edu
Jennifer B. Dean · Principal Investigator

Tampa General Hospital

Tampa, Florida, 33606

Recruiting
Site Public Contact · Contact
813-844-7829syapchanyk@tgh.org
Andrew J. Galligan · Principal Investigator

Saint Joseph's Hospital/Children's Hospital-Tampa

Tampa, Florida, 33607

Recruiting
Site Public Contact · Contact
813-357-0849jennifer.manns@baycare.org
Don E. Eslin · Principal Investigator

Saint Mary's Medical Center

West Palm Beach, Florida, 33407

Recruiting
Site Public Contact · Contact
561-822-4745
Matthew D. Ramirez · Principal Investigator

Grady Health System

Atlanta, Georgia, 30303

Recruiting
Site Public Contact · Contact
404-778-1868
Pamela B. Allen · Principal Investigator

Emory Proton Therapy Center

Atlanta, Georgia, 30308

Recruiting
Site Public Contact · Contact
404-251-2854allyson.anderson@emory.edu
Pamela B. Allen · Principal Investigator

Emory University Hospital Midtown

Atlanta, Georgia, 30308

Recruiting
Site Public Contact · Contact
888-946-7447
Pamela B. Allen · Principal Investigator

Emory University Hospital/Winship Cancer Institute

Atlanta, Georgia, 30322

Recruiting
Site Public Contact · Contact
404-778-1868
Pamela B. Allen · Principal Investigator

Children's Healthcare of Atlanta - Arthur M Blank Hospital

Atlanta, Georgia, 30329

Recruiting
Site Public Contact · Contact
404-785-0232Olivia.Floyd@choa.org
Diana Fridlyand · Principal Investigator

Emory Saint Joseph's Hospital

Atlanta, Georgia, 30342

Recruiting
Site Public Contact · Contact
404-851-7115
Pamela B. Allen · Principal Investigator

Augusta University Medical Center

Augusta, Georgia, 30912

Recruiting
Site Public Contact · Contact
706-721-2388ga_cares@augusta.edu
Colleen H. McDonough · Principal Investigator

Atrium Health Navicent

Macon, Georgia, 31201

Recruiting
Site Public Contact · Contact
478-633-2152andrew.weatherall@atriumhealth.org
Sushmita Nair · Principal Investigator

Memorial Health University Medical Center

Savannah, Georgia, 31404

Recruiting
Site Public Contact · Contact
912-350-7887Lorraine.OHara@hcahealthcare.com
Andrew L. Pendleton · Principal Investigator

Kapiolani Medical Center for Women and Children

Honolulu, Hawaii, 96826

Recruiting
Site Public Contact · Contact
808-983-6090
Wade T. Kyono · Principal Investigator

Saint Luke's Cancer Institute - Boise

Boise, Idaho, 83712

Recruiting
Site Public Contact · Contact
208-381-2774eslinget@slhs.org
Martha M. Pacheco · Principal Investigator

Saint Luke's Cancer Institute - Fruitland

Fruitland, Idaho, 83619

Recruiting
Site Public Contact · Contact
208-381-2774eslinget@slhs.org
Dan S. Zuckerman · Principal Investigator

Saint Luke's Cancer Institute - Meridian

Meridian, Idaho, 83642

Recruiting
Site Public Contact · Contact
208-381-2774eslinget@slhs.org
Dan S. Zuckerman · Principal Investigator

Saint Alphonsus Cancer Care Center-Nampa

Nampa, Idaho, 83687

Recruiting
Site Public Contact · Contact
406-969-6060mccinfo@mtcancer.org
Christopher M. Reynolds · Principal Investigator

Saint Luke's Cancer Institute - Nampa

Nampa, Idaho, 83687

Recruiting
Site Public Contact · Contact
208-381-2774eslinget@slhs.org
Dan S. Zuckerman · Principal Investigator

Saint Luke's Cancer Institute - Twin Falls

Twin Falls, Idaho, 83301

Recruiting
Site Public Contact · Contact
208-381-2774eslinget@slhs.org
Dan S. Zuckerman · Principal Investigator

Rush-Copley Medical Center

Aurora, Illinois, 60504

Recruiting
Site Public Contact · Contact
630-978-6212RCMC_Cancer_Research@rush.edu
Priyank P. Patel · Principal Investigator

Advocate Good Shepherd Hospital

Barrington, Illinois, 60010

Recruiting
Site Public Contact · Contact
847-842-4847
Rebecca E. McFall · Principal Investigator

Mount Sinai Hospital Medical Center

Chicago, Illinois, 60608

Recruiting
Site Public Contact · Contact
773-257-5960suhi@sinai.org
Pam G. Khosla · Principal Investigator

Lurie Children's Hospital-Chicago

Chicago, Illinois, 60611

Recruiting
Site Public Contact · Contact
773-880-4562
Joanna L. Weinstein · Principal Investigator

Northwestern University

Chicago, Illinois, 60611

Recruiting
Site Public Contact · Contact
312-695-1301cancer@northwestern.edu
Jane N. Winter · Principal Investigator

University of Illinois

Chicago, Illinois, 60612

Recruiting
Site Public Contact · Contact
312-355-3046
Dipti S. Dighe · Principal Investigator

Swedish Covenant Hospital

Chicago, Illinois, 60625

Recruiting
Site Public Contact · Contact
773-878-8200
Robert M. Eisner · Principal Investigator

University of Chicago Comprehensive Cancer Center

Chicago, Illinois, 60637

Recruiting
Site Public Contact · Contact
773-702-8222cancerclinicaltrials@bsd.uchicago.edu
Perry C. Morocco · Principal Investigator

Advocate Illinois Masonic Medical Center

Chicago, Illinois, 60657

Recruiting
Site Public Contact · Contact
773-296-5360
Rebecca E. McFall · Principal Investigator

AMG Crystal Lake - Oncology

Crystal Lake, Illinois, 60014

Recruiting
Site Public Contact · Contact
630-929-6129advocateresearch@advocate.com
Rebecca E. McFall · Principal Investigator

Carle at The Riverfront

Danville, Illinois, 61832

Recruiting
Site Public Contact · Contact
800-446-5532Research@Carle.com
Priyank P. Patel · Principal Investigator

Decatur Memorial Hospital

Decatur, Illinois, 62526

Recruiting
Site Public Contact · Contact
217-876-4762morganthaler.jodi@mhsil.com
Bryan A. Faller · Principal Investigator

Northwestern Medicine Cancer Center Kishwaukee

DeKalb, Illinois, 60115

Recruiting
Site Public Contact · Contact
630-352-5360Donald.Smith3@nm.org
Jane N. Winter · Principal Investigator

Advocate Good Samaritan Hospital

Downers Grove, Illinois, 60515

Recruiting
Site Public Contact · Contact
630-275-1270Barbara.barhamand@advocatehealth.com
Rebecca E. McFall · Principal Investigator

Carle Physician Group-Effingham

Effingham, Illinois, 62401

Recruiting
Site Public Contact · Contact
800-446-5532Research@carle.com
Priyank P. Patel · Principal Investigator

Crossroads Cancer Center

Effingham, Illinois, 62401

Recruiting
Site Public Contact · Contact
217-876-4762morganthaler.jodi@mhsil.com
Bryan A. Faller · Principal Investigator

Advocate Sherman Hospital

Elgin, Illinois, 60123

Recruiting
Site Public Contact · Contact
847-429-2907
Rebecca E. McFall · Principal Investigator

Elmhurst Memorial Hospital

Elmhurst, Illinois, 60126

Recruiting
Site Public Contact · Contact
630-758-5460Jrohde@emhc.org
Joseph Heng · Principal Investigator

NorthShore University HealthSystem-Evanston Hospital

Evanston, Illinois, 60201

Recruiting
Site Public Contact · Contact
847-570-2109
Robert M. Eisner · Principal Investigator

Northwestern Medicine Cancer Center Delnor

Geneva, Illinois, 60134

Recruiting
Site Public Contact · Contact
630-352-5360Donald.Smith3@nm.org
Jane N. Winter · Principal Investigator

NorthShore University HealthSystem-Glenbrook Hospital

Glenview, Illinois, 60026

Recruiting
Site Public Contact · Contact
847-570-2109
Robert M. Eisner · Principal Investigator

Northwestern Medicine Glenview Outpatient Center

Glenview, Illinois, 60026

Active Not Recruiting

Northwestern Medicine Grayslake Outpatient Center

Grayslake, Illinois, 60030

Active Not Recruiting

Advocate South Suburban Hospital

Hazel Crest, Illinois, 60429

Recruiting
Site Public Contact · Contact
708-799-9995
Rebecca E. McFall · Principal Investigator

NorthShore University HealthSystem-Highland Park Hospital

Highland Park, Illinois, 60035

Recruiting
Site Public Contact · Contact
847-570-2109
Robert M. Eisner · Principal Investigator

Northwestern Medicine Lake Forest Hospital

Lake Forest, Illinois, 60045

Active Not Recruiting

AMG Libertyville - Oncology

Libertyville, Illinois, 60048

Recruiting
Site Public Contact · Contact
630-929-6129advocateresearch@advocatehealth.com
Rebecca E. McFall · Principal Investigator

Condell Memorial Hospital

Libertyville, Illinois, 60048

Recruiting
Site Public Contact · Contact
630-929-6129advocateresearch@advocatehealth.com
Rebecca E. McFall · Principal Investigator

Carle Physician Group-Mattoon/Charleston

Mattoon, Illinois, 61938

Recruiting
Site Public Contact · Contact
800-446-5532Research@carle.com
Priyank P. Patel · Principal Investigator

Loyola University Medical Center

Maywood, Illinois, 60153

Recruiting
Site Public Contact · Contact
708-226-4357
Eugene Suh · Principal Investigator

Edward Hospital/Cancer Center

Naperville, Illinois, 60540

Recruiting
Site Public Contact · Contact
630-646-6075
Joseph Heng · Principal Investigator

HSHS Saint Elizabeth's Hospital

O'Fallon, Illinois, 62269

Recruiting
Site Public Contact · Contact
217-876-4762morganthaler.jodi@mhsil.com
Bryan A. Faller · Principal Investigator

Advocate Christ Medical Center

Oak Lawn, Illinois, 60453-2699

Recruiting
Site Public Contact · Contact
800-323-8622
Rebecca E. McFall · Principal Investigator

Advocate Children's Hospital-Oak Lawn

Oak Lawn, Illinois, 60453

Recruiting
Site Public Contact · Contact
847-723-7570
Rebecca E. McFall · Principal Investigator

Northwestern Medicine Orland Park

Orland Park, Illinois, 60462

Recruiting
Site Public Contact · Contact
nctnprogram_rhlccc@northwestern.edu
Jane N. Winter · Principal Investigator

Advocate Children's Hospital-Park Ridge

Park Ridge, Illinois, 60068

Recruiting
Site Public Contact · Contact
helpdesk@childrensoncologygroup.org
Rebecca E. McFall · Principal Investigator

Advocate Lutheran General Hospital

Park Ridge, Illinois, 60068

Recruiting
Site Public Contact · Contact
847-384-3621
Rebecca E. McFall · Principal Investigator

OSF Children's Hospital of Illinois

Peoria, Illinois, 61637

Recruiting
Site Public Contact · Contact
309-624-4945ChildrensHospitalofIllinois@osfhealthcare.org
Prerna Kumar · Principal Investigator

Edward Hospital/Cancer Center?Plainfield

Plainfield, Illinois, 60585

Recruiting
Site Public Contact · Contact
630-646-6075Cancerresearch@edward.org
Joseph Heng · Principal Investigator

UW Health Carbone Cancer Center Rockford

Rockford, Illinois, 61114

Recruiting
Site Public Contact · Contact
779-696-9378lkline@uwhealth.org
Fahrettin Covut · Principal Investigator

Memorial Hospital East

Shiloh, Illinois, 62269

Recruiting
Site Public Contact · Contact
314-747-9912dschwab@wustl.edu
Nancy L. Bartlett · Principal Investigator

Southern Illinois University School of Medicine

Springfield, Illinois, 62702

Recruiting
Site Public Contact · Contact
217-545-7929
Gregory P. Brandt · Principal Investigator

Carle Cancer Center

Urbana, Illinois, 61801

Recruiting
Site Public Contact · Contact
800-446-5532Research@carle.com
Priyank P. Patel · Principal Investigator

Northwestern Medicine Cancer Center Warrenville

Warrenville, Illinois, 60555

Recruiting
Site Public Contact · Contact
630-352-5360Donald.Smith3@nm.org
Jane N. Winter · Principal Investigator

Rush-Copley Healthcare Center

Yorkville, Illinois, 60560

Recruiting
Site Public Contact · Contact
630-978-6212Cancer.Research@rushcopley.com
Priyank P. Patel · Principal Investigator

Riley Hospital for Children

Indianapolis, Indiana, 46202

Recruiting
Site Public Contact · Contact
800-248-1199
Jennifer A. Belsky · Principal Investigator

Ascension Saint Vincent Indianapolis Hospital

Indianapolis, Indiana, 46260

Recruiting
Site Public Contact · Contact
317-338-2194research@stvincent.org
Bassem I. Razzouk · Principal Investigator

UI Health Care Mission Cancer and Blood - Ankeny Clinic

Ankeny, Iowa, 50023

Recruiting
Site Public Contact · Contact
515-241-3305
Seema Harichand-Herdt · Principal Investigator

UI Health Care Mission Cancer and Blood - West Des Moines Clinic

Clive, Iowa, 50325

Recruiting
Site Public Contact · Contact
515-241-3305
Seema Harichand-Herdt · Principal Investigator

Blank Children's Hospital

Des Moines, Iowa, 50309

Recruiting
Site Public Contact · Contact
515-241-8912samantha.mallory@unitypoint.org
Samantha L. Mallory · Principal Investigator

Iowa Methodist Medical Center

Des Moines, Iowa, 50309

Recruiting
Site Public Contact · Contact
515-241-6727
Seema Harichand-Herdt · Principal Investigator

UI Health Care Mission Cancer and Blood - Des Moines Clinic

Des Moines, Iowa, 50309

Recruiting
Site Public Contact · Contact
515-241-3305
Seema Harichand-Herdt · Principal Investigator

UI Health Care Mission Cancer and Blood - Laurel Clinic

Des Moines, Iowa, 50314

Recruiting
Site Public Contact · Contact
515-241-3305
Seema Harichand-Herdt · Principal Investigator

University of Iowa/Holden Comprehensive Cancer Center

Iowa City, Iowa, 52242

Recruiting
Site Public Contact · Contact
800-237-1225
Andrew P. Groves · Principal Investigator

UI Health Care Mission Cancer and Blood - Waukee Clinic

Waukee, Iowa, 50263

Recruiting
Site Public Contact · Contact
515-241-3305
Seema Harichand-Herdt · Principal Investigator

Wesley Medical Center

Wichita, Kansas, 67214

Recruiting
Site Public Contact · Contact
316-962-7802WesleyResearch@wesleymc.com
Nathan S. Hall · Principal Investigator

University of Kentucky/Markey Cancer Center

Lexington, Kentucky, 40536

Recruiting
Site Public Contact · Contact
859-257-3379
James T. Badgett · Principal Investigator

Norton Children's Hospital

Louisville, Kentucky, 40202

Recruiting
Site Public Contact · Contact
502-629-5500CancerResource@nortonhealthcare.org
Michael J. Ferguson · Principal Investigator

The James Graham Brown Cancer Center at University of Louisville

Louisville, Kentucky, 40202

Recruiting
Site Public Contact · Contact
502-562-3429
Hassaan Yasin · Principal Investigator

UofL Health Medical Center Northeast

Louisville, Kentucky, 40245

Recruiting
Site Public Contact · Contact
502-852-2755ctoinfo@louisville.edu
Hassaan Yasin · Principal Investigator

Children's Hospital New Orleans

New Orleans, Louisiana, 70118

Recruiting
Site Public Contact · Contact
504-894-5377
Maria C. Velez-Yanguas · Principal Investigator

Ochsner Medical Center Jefferson

New Orleans, Louisiana, 70121

Recruiting
Site Public Contact · Contact
504-842-8084Elisemarie.curry@ochsner.org
Craig Lotterman · Principal Investigator

Eastern Maine Medical Center

Bangor, Maine, 04401

Recruiting
Site Public Contact · Contact
207-973-4274
Daniel L. Callaway · Principal Investigator

MaineHealth Coastal Cancer Treatment Center

Bath, Maine, 04530

Recruiting
Site Public Contact · Contact
888-823-5923ctsucontact@westat.com
Nadav L. Kastle · Principal Investigator

MaineHealth Maine Medical Center - Portland

Portland, Maine, 04102

Recruiting
Site Public Contact · Contact
207-396-8670clinicalresearch@mainehealth.org
Nadav L. Kastle · Principal Investigator

MaineHealth Cancer Care Center of York County

Sanford, Maine, 04073

Recruiting
Site Public Contact · Contact
207-459-1600
Nadav L. Kastle · Principal Investigator

Maine Children's Cancer Program

Scarborough, Maine, 04074

Recruiting
Site Public Contact · Contact
207-396-8670clinicalresearch@mainehealth.org
Nadav L. Kastle · Principal Investigator

MaineHealth Maine Medical Center- Scarborough

Scarborough, Maine, 04074

Recruiting
Site Public Contact · Contact
207-396-8670clinicalresearch@mainehealth.org
Nadav L. Kastle · Principal Investigator

MaineHealth Cancer Care and IV Therapy - South Portland

South Portland, Maine, 04106

Recruiting
Site Public Contact · Contact
207-396-8670clinicalresearch@mainehealth.org
Nadav L. Kastle · Principal Investigator

University of Maryland/Greenebaum Cancer Center

Baltimore, Maryland, 21201

Recruiting
Site Public Contact · Contact
800-888-8823
Teresa A. York · Principal Investigator

Sinai Hospital of Baltimore

Baltimore, Maryland, 21215

Recruiting
Site Public Contact · Contact
410-601-9083
Jason M. Fixler · Principal Investigator

Johns Hopkins University/Sidney Kimmel Cancer Center

Baltimore, Maryland, 21287

Recruiting
Site Public Contact · Contact
410-955-8804jhcccro@jhmi.edu
Stacy L. Cooper · Principal Investigator

Walter Reed National Military Medical Center

Bethesda, Maryland, 20889-5600

Recruiting
Site Public Contact · Contact
301-319-2100
Kip R. Hartman · Principal Investigator

Dana-Farber Cancer Institute

Boston, Massachusetts, 02215

Recruiting
Site Public Contact · Contact
877-442-3324
Ann S. LaCasce · Principal Investigator

UMass Memorial Medical Center - University Campus

Worcester, Massachusetts, 01655

Recruiting
Site Public Contact · Contact
508-856-3216cancer.research@umassmed.edu
Stefanie R. Lowas · Principal Investigator

Trinity Health Saint Joseph Mercy Hospital Ann Arbor

Ann Arbor, Michigan, 48106

Recruiting
Site Public Contact · Contact
734-712-7251MCRCwebsitecontactform@stjoeshealth.org
Christopher M. Reynolds · Principal Investigator

C S Mott Children's Hospital

Ann Arbor, Michigan, 48109

Recruiting
Site Public Contact · Contact
800-865-1125
Jennifer E. Agrusa · Principal Investigator

Bronson Battle Creek

Battle Creek, Michigan, 49017

Recruiting
Site Public Contact · Contact
616-391-1230crcwm-regulatory@crcwm.org
Kathleen Y. Butler · Principal Investigator

Trinity Health IHA Medical Group Hematology Oncology - Brighton

Brighton, Michigan, 48114

Recruiting
Site Public Contact · Contact
734-712-7251MCRCwebsitecontactform@stjoeshealth.org
Christopher M. Reynolds · Principal Investigator

Henry Ford Cancer Institute-Downriver

Brownstown, Michigan, 48183

Recruiting
Site Public Contact · Contact
313-916-3721CTOResearch@hfhs.org
Philip Kuriakose · Principal Investigator

Trinity Health IHA Medical Group Hematology Oncology - Canton

Canton, Michigan, 48188

Recruiting
Site Public Contact · Contact
734-712-7251MCRCwebsitecontactform@stjoeshealth.org
Christopher M. Reynolds · Principal Investigator

Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital

Chelsea, Michigan, 48118

Recruiting
Site Public Contact · Contact
734-712-7251MCRCwebsitecontactform@stjoeshealth.org
Christopher M. Reynolds · Principal Investigator

Henry Ford Macomb Hospital-Clinton Township

Clinton Township, Michigan, 48038

Recruiting
Site Public Contact · Contact
313-916-3721CTOResearch@hfhs.org
Philip Kuriakose · Principal Investigator

Corewell Health Dearborn Hospital

Dearborn, Michigan, 48124

Recruiting
Site Public Contact · Contact
248-551-7695
Marie V. Nelson · Principal Investigator

Henry Ford Medical Center-Fairlane

Dearborn, Michigan, 48126

Recruiting
Site Public Contact · Contact
313-916-3721CTOResearch@hfhs.org
Philip Kuriakose · Principal Investigator

Children's Hospital of Michigan

Detroit, Michigan, 48201

Recruiting
Site Public Contact · Contact
helpdesk@childrensoncologygroup.org
Meret Henry · Principal Investigator

Wayne State University/Karmanos Cancer Institute

Detroit, Michigan, 48201

Recruiting
Site Public Contact · Contact
800-527-6266ctoadmin@karmanos.org
Dipenkumar Modi · Principal Investigator

Henry Ford Hospital

Detroit, Michigan, 48202

Recruiting
Site Public Contact · Contact
313-916-3721CTOResearch@hfhs.org
Philip Kuriakose · Principal Investigator

Michigan State University

East Lansing, Michigan, 48823

Active Not Recruiting

Weisberg Cancer Treatment Center

Farmington Hills, Michigan, 48334

Recruiting
Site Public Contact · Contact
313-576-9790ctoadmin@karmanos.org
Dipenkumar Modi · Principal Investigator

Corewell Health Farmington Hills Hospital

Farmington Hills, Michigan, 48336

Recruiting
Site Public Contact · Contact
248-551-7695
Marie V. Nelson · Principal Investigator

Corewell Health Grand Rapids Hospitals - Butterworth Hospital

Grand Rapids, Michigan, 49503

Recruiting
Site Public Contact · Contact
616-391-1230crcwm-regulatory@crcwm.org
Kathleen Y. Butler · Principal Investigator

Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital

Grand Rapids, Michigan, 49503

Recruiting
Site Public Contact · Contact
616-391-1230crcwm-regulatory@crcwm.org
Kathleen Y. Butler · Principal Investigator

Trinity Health Grand Rapids Hospital

Grand Rapids, Michigan, 49503

Recruiting
Site Public Contact · Contact
616-391-1230crcwm-regulatory@crcwm.org
Kathleen Y. Butler · Principal Investigator

Allegiance Health

Jackson, Michigan, 49201

Recruiting
Site Public Contact · Contact
313-916-3721CTOResearch@hfhs.org
Philip Kuriakose · Principal Investigator

Bronson Methodist Hospital

Kalamazoo, Michigan, 49007

Recruiting
Site Public Contact · Contact
616-391-1230crcwm-regulatory@crcwm.org
Kathleen Y. Butler · Principal Investigator

West Michigan Cancer Center

Kalamazoo, Michigan, 49007

Recruiting
Site Public Contact · Contact
616-391-1230crcwm-regulatory@crcwm.org
Kathleen Y. Butler · Principal Investigator

Beacon Kalamazoo Cancer Center

Kalamazoo, Michigan, 49009

Recruiting
Site Public Contact · Contact
574-647-7370
Kathleen Y. Butler · Principal Investigator

Trinity Health Saint Mary Mercy Livonia Hospital

Livonia, Michigan, 48154

Recruiting
Site Public Contact · Contact
734-712-7251MCRCwebsitecontactform@stjoeshealth.org
Christopher M. Reynolds · Principal Investigator

Trinity Health Muskegon Hospital

Muskegon, Michigan, 49444

Recruiting
Site Public Contact · Contact
616-391-1230crcwm-regulatory@crcwm.org
Kathleen Y. Butler · Principal Investigator

Cancer and Hematology Centers of Western Michigan - Norton Shores

Norton Shores, Michigan, 49444

Recruiting
Site Public Contact · Contact
616-391-1230connie.szczepanek@crcwm.org
Kathleen Y. Butler · Principal Investigator

Henry Ford Health Providence Novi Hospital

Novi, Michigan, 48374

Recruiting
Site Public Contact · Contact
248-849-5332kfife3@hfhs.org
Philip Kuriakose · Principal Investigator

Henry Ford Medical Center-Columbus

Novi, Michigan, 48377

Recruiting
Site Public Contact · Contact
313-916-3721CTOResearch@hfhs.org
Philip Kuriakose · Principal Investigator

Trinity Health Saint Joseph Mercy Oakland Hospital

Pontiac, Michigan, 48341

Recruiting
Site Public Contact · Contact
734-712-7251MCRCwebsitecontactform@stjoeshealth.org
Christopher M. Reynolds · Principal Investigator

Corewell Health Reed City Hospital

Reed City, Michigan, 49677

Recruiting
Site Public Contact · Contact
616-391-1230crcwm-regulatory@crcwm.org
Kathleen Y. Butler · Principal Investigator

Corewell Health Children's

Royal Oak, Michigan, 48073

Recruiting
Site Public Contact · Contact
248-551-7695
Marie V. Nelson · Principal Investigator

Corewell Health William Beaumont University Hospital

Royal Oak, Michigan, 48073

Recruiting
Site Public Contact · Contact
248-551-7695
Marie V. Nelson · Principal Investigator

Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center

Saint Joseph, Michigan, 49085

Recruiting
Site Public Contact · Contact
616-391-1230crcwm-regulatory@crcwm.org
Kathleen Y. Butler · Principal Investigator

Henry Ford Health Providence Southfield Hospital

Southfield, Michigan, 48075

Recruiting
Site Public Contact · Contact
248-849-5332kfife3@hfhs.org
Philip Kuriakose · Principal Investigator

Munson Medical Center

Traverse City, Michigan, 49684

Recruiting
Site Public Contact · Contact
616-391-1230crcwm-regulatory@crcwm.org
Kathleen Y. Butler · Principal Investigator

Corewell Health Beaumont Troy Hospital

Troy, Michigan, 48085

Recruiting
Site Public Contact · Contact
248-551-7695
Marie V. Nelson · Principal Investigator

Henry Ford West Bloomfield Hospital

West Bloomfield, Michigan, 48322

Recruiting
Site Public Contact · Contact
313-916-3721CTOResearch@hfhs.org
Philip Kuriakose · Principal Investigator

Henry Ford Wyandotte Hospital

Wyandotte, Michigan, 48192

Recruiting
Site Public Contact · Contact
nhay@hfhs.org
Philip Kuriakose · Principal Investigator

University of Michigan Health - West

Wyoming, Michigan, 49519

Recruiting
Site Public Contact · Contact
616-391-1230crcwm-regulatory@crcwm.org
Kathleen Y. Butler · Principal Investigator

Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus

Ypsilanti, Michigan, 48197

Recruiting
Site Public Contact · Contact
734-712-7251MCRCwebsitecontactform@stjoeshealth.org
Christopher M. Reynolds · Principal Investigator

Mercy Hospital

Coon Rapids, Minnesota, 55433

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

Fairview Southdale Hospital

Edina, Minnesota, 55435

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

Children's Hospitals and Clinics of Minnesota - Minneapolis

Minneapolis, Minnesota, 55404

Recruiting
Site Public Contact · Contact
612-813-5913pauline.mitby@childrensmn.org
Michael K. Richards · Principal Investigator

Abbott-Northwestern Hospital

Minneapolis, Minnesota, 55407

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

University of Minnesota/Masonic Cancer Center

Minneapolis, Minnesota, 55455

Recruiting
Site Public Contact · Contact
612-624-2620
Peter M. Gordon · Principal Investigator

Mayo Clinic in Rochester

Rochester, Minnesota, 55905

Recruiting
Site Public Contact · Contact
855-776-0015
Mira Kohorst · Principal Investigator

Park Nicollet Clinic - Saint Louis Park

Saint Louis Park, Minnesota, 55416

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

Regions Hospital

Saint Paul, Minnesota, 55101

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

United Hospital

Saint Paul, Minnesota, 55102

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

Minnesota Oncology Hematology PA-Woodbury

Woodbury, Minnesota, 55125

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

University of Mississippi Medical Center

Jackson, Mississippi, 39216

Recruiting
Site Public Contact · Contact
601-815-6700
Amanda Strobel · Principal Investigator

Saint Francis Medical Center

Cape Girardeau, Missouri, 63703

Recruiting
Site Public Contact · Contact
573-334-2230sfmc@sfmc.net
Bryan A. Faller · Principal Investigator

Saint Luke's Hospital

Chesterfield, Missouri, 63017

Recruiting
Site Public Contact · Contact
314-205-6936
Mark J. Fesler · Principal Investigator

Siteman Cancer Center at Saint Peters Hospital

City of Saint Peters, Missouri, 63376

Recruiting
Site Public Contact · Contact
800-600-3606info@siteman.wustl.edu
Nancy L. Bartlett · Principal Investigator

University of Missouri Children's Hospital

Columbia, Missouri, 65212

Recruiting
Site Public Contact · Contact
573-882-1960snwq62@health.missouri.edu
Barbara A. Gruner · Principal Investigator

Siteman Cancer Center at West County Hospital

Creve Coeur, Missouri, 63141

Recruiting
Site Public Contact · Contact
800-600-3606info@siteman.wustl.edu
Nancy L. Bartlett · Principal Investigator

Children's Mercy Hospitals and Clinics

Kansas City, Missouri, 64108

Recruiting
Site Public Contact · Contact
816-302-6808COGResearchGroup@cmh.edu
Keith J. August · Principal Investigator

Cardinal Glennon Children's Medical Center

St Louis, Missouri, 63104

Recruiting
Site Public Contact · Contact
314-268-4000
William S. Ferguson · Principal Investigator

Washington University School of Medicine

St Louis, Missouri, 63110

Recruiting
Site Public Contact · Contact
800-600-3606info@siteman.wustl.edu
Nancy L. Bartlett · Principal Investigator

Siteman Cancer Center-South County

St Louis, Missouri, 63129

Recruiting
Site Public Contact · Contact
800-600-3606info@siteman.wustl.edu
Nancy L. Bartlett · Principal Investigator

Siteman Cancer Center at Christian Hospital

St Louis, Missouri, 63136

Recruiting
Site Public Contact · Contact
800-600-3606info@siteman.wustl.edu
Nancy L. Bartlett · Principal Investigator

Mercy Hospital Saint Louis

St Louis, Missouri, 63141

Recruiting
Site Public Contact · Contact
314-251-7066
Robin D. Hanson · Principal Investigator

Nebraska Medicine-Bellevue

Bellevue, Nebraska, 68123

Recruiting
Site Public Contact · Contact
402-559-6941unmcrsa@unmc.edu
Jill C. Beck · Principal Investigator

Children's Hospital and Medical Center of Omaha

Omaha, Nebraska, 68114

Recruiting
Site Public Contact · Contact
402-955-3949
Jill C. Beck · Principal Investigator

Nebraska Medicine-Village Pointe

Omaha, Nebraska, 68118

Recruiting
Site Public Contact · Contact
402-559-5600
Jill C. Beck · Principal Investigator

University of Nebraska Medical Center

Omaha, Nebraska, 68198

Recruiting
Site Public Contact · Contact
402-559-6941unmcrsa@unmc.edu
Jill C. Beck · Principal Investigator

Alliance for Childhood Diseases/Cure 4 the Kids Foundation

Las Vegas, Nevada, 89135

Recruiting
Site Public Contact · Contact
702-384-0013research@sncrf.org
Alan K. Ikeda · Principal Investigator

Renown Regional Medical Center

Reno, Nevada, 89502

Recruiting
Site Public Contact · Contact
702-384-0013research@sncrf.org
Alan K. Ikeda · Principal Investigator

Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center

Lebanon, New Hampshire, 03756

Recruiting
Site Public Contact · Contact
800-639-6918cancer.research.nurse@dartmouth.edu
Angela Ricci · Principal Investigator

Cooper Hospital University Medical Center

Camden, New Jersey, 08103

Recruiting
Site Public Contact · Contact
856-325-6757
Sushil Ghimire · Principal Investigator

Trinitas Hospital and Comprehensive Cancer Center - Williamson Street Campus

Elizabeth, New Jersey, 07207

Recruiting
Site Public Contact · Contact
908-994-8000
Richard A. Drachtman · Principal Investigator

Hunterdon Medical Center

Flemington, New Jersey, 08822

Recruiting
Site Public Contact · Contact
908-237-2330
Myron E. Bednar · Principal Investigator

Hackensack University Medical Center

Hackensack, New Jersey, 07601

Recruiting
Site Public Contact · Contact
551-996-2897
Burton E. Appel · Principal Investigator

Jersey City Medical Center

Jersey City, New Jersey, 07302

Recruiting
Site Public Contact · Contact
888-823-5923ctsucontact@westat.com
Richard A. Drachtman · Principal Investigator

Saint Barnabas Medical Center

Livingston, New Jersey, 07039

Recruiting
Site Public Contact · Contact
973-322-2934joanne.loeb@rwjbh.org
Richard A. Drachtman · Principal Investigator

Monmouth Medical Center

Long Branch, New Jersey, 07740

Recruiting
Site Public Contact · Contact
732-923-6564mary.danish@rwjbh.org
Richard A. Drachtman · Principal Investigator

Morristown Medical Center

Morristown, New Jersey, 07960

Recruiting
Site Public Contact · Contact
973-971-5900
Kathryn L. Laurie · Principal Investigator

Jersey Shore Medical Center

Neptune City, New Jersey, 07753

Recruiting
Site Public Contact · Contact
732-776-4240
Burton E. Appel · Principal Investigator

Saint Peter's University Hospital

New Brunswick, New Jersey, 08901

Recruiting
Site Public Contact · Contact
732-745-8600kcovert@saintpetersuh.com
Nibal A. Zaghloul · Principal Investigator

Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital

New Brunswick, New Jersey, 08903

Recruiting
Site Public Contact · Contact
732-235-8675
Richard A. Drachtman · Principal Investigator

Rutgers Cancer Institute of New Jersey

New Brunswick, New Jersey, 08903

Recruiting
Site Public Contact · Contact
732-235-7356
Richard A. Drachtman · Principal Investigator

Newark Beth Israel Medical Center

Newark, New Jersey, 07112

Recruiting
Site Public Contact · Contact
973-926-7230Christine.Kosmides@rwjbh.org
Teena Bhatla · Principal Investigator

Saint Joseph's Regional Medical Center

Paterson, New Jersey, 07503

Recruiting
Site Public Contact · Contact
973-754-2207HallL@sjhmc.org
Alissa Kahn · Principal Investigator

Community Medical Center

Toms River, New Jersey, 08755

Recruiting
Site Public Contact · Contact
732-557-8294Lennette.Gonzales@rwjbh.org
Richard A. Drachtman · Principal Investigator

Presbyterian Hospital

Albuquerque, New Mexico, 87106

Recruiting
Site Public Contact · Contact
505-559-6113wburman@phs.org
Beeling Armijo · Principal Investigator

University of New Mexico Cancer Center

Albuquerque, New Mexico, 87106

Suspended

Albany Medical Center

Albany, New York, 12208

Recruiting
Site Public Contact · Contact
518-262-5513
Lauren R. Weintraub · Principal Investigator

Roswell Park Cancer Institute

Buffalo, New York, 14263

Recruiting
Site Public Contact · Contact
800-767-9355askroswell@roswellpark.org
Kara M. Kelly · Principal Investigator

Hematology Oncology Associates of CNY at Camillus

Camillus, New York, 13031

Recruiting
Site Public Contact · Contact
315-472-7504
Steven M. Duffy · Principal Investigator

Hematology Oncology Associates of Central New York-East Syracuse

East Syracuse, New York, 13057

Recruiting
Site Public Contact · Contact
315-472-7504
Steven M. Duffy · Principal Investigator

Glens Falls Hospital

Glens Falls, New York, 12801

Recruiting
Site Public Contact · Contact
518-926-6700
Christopher R. Mason · Principal Investigator

NYU Langone Hospital - Long Island

Mineola, New York, 11501

Recruiting
Site Public Contact · Contact
212-263-4432cancertrials@nyulangone.org
Chana L. Glasser · Principal Investigator

The Steven and Alexandra Cohen Children's Medical Center of New York

New Hyde Park, New York, 11040

Recruiting
Site Public Contact · Contact
718-470-3460
Arlene S. Redner · Principal Investigator

Laura and Isaac Perlmutter Cancer Center at NYU Langone

New York, New York, 10016

Recruiting
Site Public Contact · Contact
CancerTrials@nyulangone.org
Elizabeth A. Raetz · Principal Investigator

Mount Sinai Hospital

New York, New York, 10029

Recruiting
Site Public Contact · Contact
212-824-7309CCTO@mssm.edu
Pamela R. Merola · Principal Investigator

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center

New York, New York, 10032

Recruiting
Site Public Contact · Contact
212-342-5162cancerclinicaltrials@cumc.columbia.edu
Nobuko Hijiya · Principal Investigator

Memorial Sloan Kettering Cancer Center

New York, New York, 10065

Recruiting
Site Public Contact · Contact
212-639-7592
Christopher J. Forlenza · Principal Investigator

NYP/Weill Cornell Medical Center

New York, New York, 10065

Recruiting
Site Public Contact · Contact
212-746-1848
Nitya Gulati · Principal Investigator

University of Rochester

Rochester, New York, 14642

Recruiting
Site Public Contact · Contact
585-275-5830
Carla Casulo · Principal Investigator

Stony Brook University Medical Center

Stony Brook, New York, 11794

Recruiting
Site Public Contact · Contact
800-862-2215
Laura E. Hogan · Principal Investigator

State University of New York Upstate Medical University

Syracuse, New York, 13210

Recruiting
Site Public Contact · Contact
315-464-5476
Melanie A. Comito · Principal Investigator

Montefiore Medical Center - Moses Campus

The Bronx, New York, 10467

Recruiting
Site Public Contact · Contact
718-379-6866eskwak@montefiore.org
Alice Lee · Principal Investigator

Wilmot Cancer Institute at Webster

Webster, New York, 14580

Recruiting
Site Public Contact · Contact
WCICTOresearch@urmc.rochester.edu
Carla Casulo · Principal Investigator

Mission Hospital

Asheville, North Carolina, 28801

Recruiting
Site Public Contact · Contact
828-213-7055NCDV.ResearchRegulatory@HCAHealthcare.com
Douglas J. Scothorn · Principal Investigator

UNC Lineberger Comprehensive Cancer Center

Chapel Hill, North Carolina, 27599

Recruiting
Site Public Contact · Contact
877-668-0683cancerclinicaltrials@med.unc.edu
Natalie S. Grover · Principal Investigator

Carolinas Medical Center/Levine Cancer Institute

Charlotte, North Carolina, 28203

Recruiting
Site Public Contact · Contact
800-804-9376
Joel A. Kaplan · Principal Investigator

Duke University Medical Center

Durham, North Carolina, 27710

Recruiting
Site Public Contact · Contact
888-275-3853
Jessica M. Sun · Principal Investigator

East Carolina University

Greenville, North Carolina, 27834

Recruiting
Site Public Contact · Contact
252-744-1015eubankss@ecu.edu
Andrea R. Whitfield · Principal Investigator

Wake Forest University Health Sciences

Winston-Salem, North Carolina, 27157

Recruiting
Site Public Contact · Contact
336-713-6771
Sarah Supples · Principal Investigator

Sanford Broadway Medical Center

Fargo, North Dakota, 58122

Recruiting
Site Public Contact · Contact
701-323-5760OncologyClinicalTrialsFargo@sanfordhealth.org
Samuel J. Milanovich · Principal Investigator

Children's Hospital Medical Center of Akron

Akron, Ohio, 44308

Recruiting
Site Public Contact · Contact
330-543-3193
Erin Wright · Principal Investigator

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, 45229

Recruiting
Site Public Contact · Contact
513-636-2799cancer@cchmc.org
Robin E. Norris · Principal Investigator

Rainbow Babies and Childrens Hospital

Cleveland, Ohio, 44106

Recruiting
Site Public Contact · Contact
216-844-5437
Duncan S. Stearns · Principal Investigator

Cleveland Clinic Foundation

Cleveland, Ohio, 44195

Recruiting
Site Public Contact · Contact
866-223-8100TaussigResearch@ccf.org
Matteo M. Trucco · Principal Investigator

Nationwide Children's Hospital

Columbus, Ohio, 43205

Recruiting
Site Public Contact · Contact
614-722-6039Melinda.Triplet@nationwidechildrens.org
Mark A. Ranalli · Principal Investigator

Dayton Children's Hospital

Dayton, Ohio, 45404

Recruiting
Site Public Contact · Contact
800-228-4055
Jordan M. Wright · Principal Investigator

ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital

Toledo, Ohio, 43606

Recruiting
Site Public Contact · Contact
419-824-1842PCIOncResearch@promedica.org
Jamie L. Dargart · Principal Investigator

University of Oklahoma Health Sciences Center

Oklahoma City, Oklahoma, 73104

Recruiting
Site Public Contact · Contact
405-271-8777ou-clinical-trials@ouhsc.edu
Rene Y. McNall-Knapp · Principal Investigator

Natalie Warren Bryant Cancer Center at Saint Francis

Tulsa, Oklahoma, 74136

Recruiting
Site Public Contact · Contact
918-494-2200
Jill A. Salo · Principal Investigator

Providence Newberg Medical Center

Newberg, Oregon, 97132

Recruiting
Site Public Contact · Contact
503-215-2614CanRsrchStudies@providence.org
Dan S. Zuckerman · Principal Investigator

Providence Willamette Falls Medical Center

Oregon City, Oregon, 97045

Recruiting
Site Public Contact · Contact
503-215-2614CanRsrchStudies@providence.org
Dan S. Zuckerman · Principal Investigator

Providence Portland Medical Center

Portland, Oregon, 97213

Recruiting
Site Public Contact · Contact
503-215-2614CanRsrchStudies@providence.org
Dan S. Zuckerman · Principal Investigator

Providence Saint Vincent Medical Center

Portland, Oregon, 97225

Recruiting
Site Public Contact · Contact
503-215-2614CanRsrchStudies@providence.org
Dan S. Zuckerman · Principal Investigator

Legacy Emanuel Children's Hospital

Portland, Oregon, 97227

Recruiting
Site Public Contact · Contact
503-413-2560
Jason M. Glover · Principal Investigator

Oregon Health and Science University

Portland, Oregon, 97239

Recruiting
Site Public Contact · Contact
503-494-1080trials@ohsu.edu
Bill H. Chang · Principal Investigator

Lehigh Valley Hospital-Cedar Crest

Allentown, Pennsylvania, 18103

Recruiting
Site Public Contact · Contact
610-402-9543Morgan_M.Horton@lvhn.org
Christopher M. Reynolds · Principal Investigator

Geisinger Medical Center

Danville, Pennsylvania, 17822

Recruiting
Site Public Contact · Contact
570-271-5251HemonCCTrials@geisinger.edu
Jagadeesh Ramdas · Principal Investigator

Penn State Children's Hospital

Hershey, Pennsylvania, 17033

Recruiting
Site Public Contact · Contact
717-531-6012
Lisa M. McGregor · Principal Investigator

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, 19104

Recruiting
Site Public Contact · Contact
267-425-5544CancerTrials@email.chop.edu
Leslie S. Kersun · Principal Investigator

Thomas Jefferson University Hospital

Philadelphia, Pennsylvania, 19107

Recruiting
Site Public Contact · Contact
215-600-9151ONCTrialNow@jefferson.edu
Seyfettin O. Alpdogan · Principal Investigator

Saint Christopher's Hospital for Children

Philadelphia, Pennsylvania, 19134

Recruiting
Site Public Contact · Contact
215-427-8991
Gregory E. Halligan · Principal Investigator

Children's Hospital of Pittsburgh of UPMC

Pittsburgh, Pennsylvania, 15224

Recruiting
Site Public Contact · Contact
412-692-8570jean.tersak@chp.edu
Jean M. Tersak · Principal Investigator

Rhode Island Hospital

Providence, Rhode Island, 02903

Recruiting
Site Public Contact · Contact
401-444-1488
Bradley DeNardo · Principal Investigator

Smilow Cancer Hospital Care Center - Westerly

Westerly, Rhode Island, 02891

Recruiting
Site Public Contact · Contact
203-785-5702canceranswers@yale.edu
Farzana Pashankar · Principal Investigator

Prisma Health Cancer Institute - Spartanburg

Boiling Springs, South Carolina, 29316

Recruiting
Site Public Contact · Contact
864-522-4317Kim.Williams3@prismahealth.org
Aniket Saha · Principal Investigator

Medical University of South Carolina

Charleston, South Carolina, 29425

Recruiting
Site Public Contact · Contact
843-792-9321hcc-clinical-trials@musc.edu
Jacqueline M. Kraveka · Principal Investigator

Prisma Health Richland Hospital

Columbia, South Carolina, 29203

Recruiting
Site Public Contact · Contact
864-522-4317Kim.Williams3@prismahealth.org
Stuart L. Cramer · Principal Investigator

Saint Francis Hospital

Greenville, South Carolina, 29601

Recruiting
Site Public Contact · Contact
864-603-6234Heather_Rich@bshsi.org
Stephen H. Dyar · Principal Investigator

BI-LO Charities Children's Cancer Center

Greenville, South Carolina, 29605

Recruiting
Site Public Contact · Contact
864-522-4317Kim.Williams3@prismahealth.org
Aniket Saha · Principal Investigator

Saint Francis Cancer Center

Greenville, South Carolina, 29607

Recruiting
Site Public Contact · Contact
864-603-6234Heather_Rich@bshsi.org
Stephen H. Dyar · Principal Investigator

Prisma Health Cancer Institute - Eastside

Greenville, South Carolina, 29615

Recruiting
Site Public Contact · Contact
864-522-4317Kim.Williams3@prismahealth.org
Aniket Saha · Principal Investigator

Sanford USD Medical Center - Sioux Falls

Sioux Falls, South Dakota, 57117-5134

Recruiting
Site Public Contact · Contact
605-312-3320OncologyClinicalTrialsSF@SanfordHealth.org
Kayelyn J. Wagner · Principal Investigator

T C Thompson Children's Hospital

Chattanooga, Tennessee, 37403

Recruiting
Site Public Contact · Contact
423-778-7289
Benjamin A. Mixon · Principal Investigator

East Tennessee Childrens Hospital

Knoxville, Tennessee, 37916

Recruiting
Site Public Contact · Contact
865-541-8266
Susan E. Spiller · Principal Investigator

The Children's Hospital at TriStar Centennial

Nashville, Tennessee, 37203

Recruiting
Site Public Contact · Contact
615-342-1919
Clinton M. Carroll · Principal Investigator

Vanderbilt University/Ingram Cancer Center

Nashville, Tennessee, 37232

Recruiting
Site Public Contact · Contact
800-811-8480
Christine M. Smith · Principal Investigator

Dell Children's Medical Center of Central Texas

Austin, Texas, 78723

Recruiting
Site Public Contact · Contact
512-628-1902TXAUS-DL-SFCHemonc.research@ascension.org
Shannon M. Cohn · Principal Investigator

Driscoll Children's Hospital

Corpus Christi, Texas, 78411

Recruiting
Site Public Contact · Contact
361-694-5311Crystal.DeLosSantos@dchstx.org
Nkechi I. Mba · Principal Investigator

Medical City Dallas Hospital

Dallas, Texas, 75230

Recruiting
Site Public Contact · Contact
972-566-5588
Maurizio L. Ghisoli · Principal Investigator

UT Southwestern/Simmons Cancer Center-Dallas

Dallas, Texas, 75390

Recruiting
Site Public Contact · Contact
214-648-7097canceranswerline@UTSouthwestern.edu
Ksenya Shliakhtsitsava · Principal Investigator

El Paso Children's Hospital

El Paso, Texas, 79905

Recruiting
Site Public Contact · Contact
915-298-5444ranjan.bista@ttuhsc.edu
Benjamin Carcamo · Principal Investigator

Cook Children's Medical Center

Fort Worth, Texas, 76104

Recruiting
Site Public Contact · Contact
682-885-2103CookChildrensResearch@cookchildrens.org
Karen H. Albritton · Principal Investigator

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center

Houston, Texas, 77030

Recruiting
Site Public Contact · Contact
713-798-1354burton@bcm.edu
Kala Y. Kamdar · Principal Investigator

UT MD Anderson Cancer Center

Houston, Texas, 77030

Recruiting
Site Public Contact · Contact
866-632-6789askmdanderson@mdanderson.org
Najat C. Daw · Principal Investigator

Covenant Children's Hospital

Lubbock, Texas, 79410

Recruiting
Site Public Contact · Contact
806-725-8657mbisbee@providence.org
Kishor M. Bhende · Principal Investigator

UMC Cancer Center / UMC Health System

Lubbock, Texas, 79415

Recruiting
Site Public Contact · Contact
806-775-8590
Erin K. Barr · Principal Investigator

Children's Hospital of San Antonio

San Antonio, Texas, 78207

Recruiting
Site Public Contact · Contact
210-704-2894bridget.medina@christushealth.org
Julie Voeller · Principal Investigator

Methodist Children's Hospital of South Texas

San Antonio, Texas, 78229

Recruiting
Site Public Contact · Contact
210-575-6240Vinod.GidvaniDiaz@hcahealthcare.com
Jose M. Esquilin · Principal Investigator

University of Texas Health Science Center at San Antonio

San Antonio, Texas, 78229

Recruiting
Site Public Contact · Contact
210-450-3800phoresearchoffice@uthscsa.edu
Allison C. Grimes · Principal Investigator

Scott and White Memorial Hospital

Temple, Texas, 76508

Recruiting
Site Public Contact · Contact
254-724-5407
Nicholas W. McGregor · Principal Investigator

Huntsman Cancer Institute/University of Utah

Salt Lake City, Utah, 84112

Recruiting
Site Public Contact · Contact
888-424-2100cancerinfo@hci.utah.edu
Boyu Hu · Principal Investigator

Primary Children's Hospital

Salt Lake City, Utah, 84113

Recruiting
Site Public Contact · Contact
801-585-5270
Mallorie B. Heneghan · Principal Investigator

University of Vermont and State Agricultural College

Burlington, Vermont, 05405

Recruiting
Site Public Contact · Contact
802-656-8990rpo@uvm.edu
Jessica L. Heath · Principal Investigator

University of Virginia Cancer Center

Charlottesville, Virginia, 22908

Recruiting
Site Public Contact · Contact
434-243-6303uvacancertrials@hscmail.mcc.virginia.edu
Brian C. Belyea · Principal Investigator

Inova Fairfax Hospital

Falls Church, Virginia, 22042

Recruiting
Site Public Contact · Contact
703-208-6650Stephanie.VanBebber@inova.org
Robin Y. Dulman · Principal Investigator

Children's Hospital of The King's Daughters

Norfolk, Virginia, 23507

Recruiting
Site Public Contact · Contact
757-668-7243CCBDCresearch@chkd.org
Melissa S. Mark · Principal Investigator

Naval Medical Center - Portsmouth

Portsmouth, Virginia, 23708-2197

Recruiting
Site Public Contact · Contact
757-953-5939
Karin Brockman · Principal Investigator

VCU Massey Comprehensive Cancer Center

Richmond, Virginia, 23298

Recruiting
Site Public Contact · Contact
804-628-6430CTOclinops@vcu.edu
Jordyn R. Griffin · Principal Investigator

Carilion Children's

Roanoke, Virginia, 24014

Recruiting
Site Public Contact · Contact
540-266-6238wpmccarty@carilionclinic.org
Erwood G. Edwards · Principal Investigator

Valley Medical Center

Renton, Washington, 98055

Recruiting
Site Public Contact · Contact
425-228-3440research@valleymed.org
Alan K. Ikeda · Principal Investigator

Seattle Children's Hospital

Seattle, Washington, 98105

Recruiting
Site Public Contact · Contact
866-987-2000
Sarah E. Leary · Principal Investigator

Providence Sacred Heart Medical Center and Children's Hospital

Spokane, Washington, 99204

Recruiting
Site Public Contact · Contact
800-228-6618HopeBeginsHere@providence.org
Judy L. Felgenhauer · Principal Investigator

Mary Bridge Children's Hospital and Health Center

Tacoma, Washington, 98405

Recruiting
Site Public Contact · Contact
253-403-1461research@multicare.org
Robert G. Irwin · Principal Investigator

West Virginia University Charleston Division

Charleston, West Virginia, 25304

Recruiting
Site Public Contact · Contact
304-388-9944
Mohamad H. Badawi · Principal Investigator

Edwards Comprehensive Cancer Center

Huntington, West Virginia, 25701

Recruiting
Site Public Contact · Contact
304-399-6566Christina.Cole@chhi.org
Mark A. Ranalli · Principal Investigator

Aurora Cancer Care-Southern Lakes VLCC

Burlington, Wisconsin, 53105

Recruiting
Site Public Contact · Contact
414-302-2304ncorp@aurora.org
Rebecca E. McFall · Principal Investigator

Aurora Saint Luke's South Shore

Cudahy, Wisconsin, 53110

Recruiting
Site Public Contact · Contact
414-302-2304ncorp@aurora.org
Rebecca E. McFall · Principal Investigator

Aurora Health Care Germantown Health Center

Germantown, Wisconsin, 53022

Recruiting
Site Public Contact · Contact
414-302-2304ncorp@aurora.org
Rebecca E. McFall · Principal Investigator

Aurora Cancer Care-Grafton

Grafton, Wisconsin, 53024

Recruiting
Site Public Contact · Contact
414-302-2304ncorp@aurora.org
Rebecca E. McFall · Principal Investigator

Saint Vincent Hospital Cancer Center Green Bay

Green Bay, Wisconsin, 54301

Recruiting
Site Public Contact · Contact
920-433-8889WI_research_admin@hshs.org
Catherine A. Long · Principal Investigator

Aurora BayCare Medical Center

Green Bay, Wisconsin, 54311

Recruiting
Site Public Contact · Contact
414-302-2304ncorp@aurora.org
Rebecca E. McFall · Principal Investigator

Aurora Cancer Care-Kenosha South

Kenosha, Wisconsin, 53142

Recruiting
Site Public Contact · Contact
414-302-2304ncorp@aurora.org
Rebecca E. McFall · Principal Investigator

Gundersen Lutheran Medical Center

La Crosse, Wisconsin, 54601

Recruiting
Site Public Contact · Contact
608-775-2385cancerctr@gundersenhealth.org
Kurt Oettel · Principal Investigator

University of Wisconsin Carbone Cancer Center - Eastpark Medical Center

Madison, Wisconsin, 53718

Recruiting
Site Public Contact · Contact
800-622-8922clinicaltrials@cancer.wisc.edu
Priyanka Pophali · Principal Investigator

University of Wisconsin Carbone Cancer Center - University Hospital

Madison, Wisconsin, 53792

Recruiting
Site Public Contact · Contact
800-622-8922clinicaltrials@cancer.wisc.edu
Priyanka Pophali · Principal Investigator

Aurora Bay Area Medical Group-Marinette

Marinette, Wisconsin, 54143

Recruiting
Site Public Contact · Contact
414-302-2304ncorp@aurora.org
Rebecca E. McFall · Principal Investigator

Marshfield Medical Center-Marshfield

Marshfield, Wisconsin, 54449

Recruiting
Site Public Contact · Contact
800-782-8581oncology.clinical.trials@marshfieldresearch.org
Michelle A. Manalang · Principal Investigator

Aurora Cancer Care-Milwaukee

Milwaukee, Wisconsin, 53209

Recruiting
Site Public Contact · Contact
414-302-2304ncorp@aurora.org
Rebecca E. McFall · Principal Investigator

Aurora Saint Luke's Medical Center

Milwaukee, Wisconsin, 53215

Recruiting
Site Public Contact · Contact
414-302-2304ncorp@aurora.org
Rebecca E. McFall · Principal Investigator

Children's Hospital of Wisconsin

Milwaukee, Wisconsin, 53226

Recruiting
Site Public Contact · Contact
414-955-4727MACCCTO@mcw.edu
Michael J. Burke · Principal Investigator

Aurora Sinai Medical Center

Milwaukee, Wisconsin, 53233

Recruiting
Site Public Contact · Contact
414-302-2304ncorp@aurora.org
Rebecca E. McFall · Principal Investigator

ProHealth D N Greenwald Center

Mukwonago, Wisconsin, 53149

Recruiting
Site Public Contact · Contact
research.institute@phci.org
Timothy R. Wassenaar · Principal Investigator

ProHealth Oconomowoc Memorial Hospital

Oconomowoc, Wisconsin, 53066

Recruiting
Site Public Contact · Contact
262-928-7878
Timothy R. Wassenaar · Principal Investigator

Vince Lombardi Cancer Clinic - Oshkosh

Oshkosh, Wisconsin, 54904

Recruiting
Site Public Contact · Contact
414-302-2304ncorp@aurora.org
Rebecca E. McFall · Principal Investigator

Aurora Cancer Care-Racine

Racine, Wisconsin, 53406

Recruiting
Site Public Contact · Contact
414-302-2304ncorp@aurora.org
Rebecca E. McFall · Principal Investigator

Saint Vincent Hospital Cancer Center at Sheboygan

Sheboygan, Wisconsin, 53081

Recruiting
Site Public Contact · Contact
920-433-8889wi_research_admin@hshs.org
Catherine A. Long · Principal Investigator

Vince Lombardi Cancer Clinic-Sheboygan

Sheboygan, Wisconsin, 53081

Recruiting
Site Public Contact · Contact
414-302-2304ncorp@aurora.org
Rebecca E. McFall · Principal Investigator

Saint Vincent Hospital Cancer Center at Sturgeon Bay

Sturgeon Bay, Wisconsin, 54235-1495

Recruiting
Site Public Contact · Contact
920-433-8889wi_research_admin@hshs.org
Catherine A. Long · Principal Investigator

Aurora Medical Center in Summit

Summit, Wisconsin, 53066

Recruiting
Site Public Contact · Contact
414-302-2304ncorp@aurora.org
Rebecca E. McFall · Principal Investigator

Vince Lombardi Cancer Clinic-Two Rivers

Two Rivers, Wisconsin, 54241

Recruiting
Site Public Contact · Contact
414-302-2304ncorp@aurora.org
Rebecca E. McFall · Principal Investigator

UW Cancer Center at ProHealth Care

Waukesha, Wisconsin, 53188

Recruiting
Site Public Contact · Contact
262-928-5539Chanda.miller@phci.org
Timothy R. Wassenaar · Principal Investigator

Aurora Cancer Care-Milwaukee West

Wauwatosa, Wisconsin, 53226

Recruiting
Site Public Contact · Contact
414-302-2304ncorp@aurora.org
Rebecca E. McFall · Principal Investigator

Aurora West Allis Medical Center

West Allis, Wisconsin, 53227

Recruiting
Site Public Contact · Contact
414-302-2304ncorp@aurora.org
Rebecca E. McFall · Principal Investigator

References

  • Castellino SM, Giulino-Roth L, Harker-Murray P, Kahn JM, Forlenza C, Cho S, Hoppe B, Parsons SK, Kelly KM; COG Hodgkin Lymphoma Committee. Children's Oncology Group's 2023 blueprint for research: Hodgkin lymphoma. Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30580. doi: 10.1002/pbc.30580. Epub 2023 Jul 28.(PubMed)